Pioglitazone does not increase the risk of type II diabetes in patients with bladder cancer: A retrospective study

The aim of the retrospective study was to analyze the effect of pioglitazone on the expression of tumor tissue inflammation factor interleukin (IL)-8, macrophage colony-stimulating factor (M-CSF) and vascular endothelial growth factor (VEGF) of type II diabetes in bladder cancer patients. In additio...

Descripción completa

Detalles Bibliográficos
Autores principales: DONG, YOUHONG, WANG, ANPING
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4907043/
https://www.ncbi.nlm.nih.gov/pubmed/27347105
http://dx.doi.org/10.3892/ol.2016.4566

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4907043/
https://www.ncbi.nlm.nih.gov/pubmed/27347105
http://dx.doi.org/10.3892/ol.2016.4566

Ejemplares similares